These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7389234)

  • 1. Antipyrine half-life and drug elimination.
    Breckenridge A
    Clin Pharmacokinet; 1980; 5(3):201-3. PubMed ID: 7389234
    [No Abstract]   [Full Text] [Related]  

  • 2. Interindividual differences in drug oxidation: clinical importance.
    Sjöqvist F; von Bahr C
    Drug Metab Dispos; 1973; 1(1):469-82. PubMed ID: 4149420
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of nifedipine on hepatic drug oxidation.
    Dickinson TH; Egan JM; Abernethy DR
    Pharmacology; 1988; 36(6):405-10. PubMed ID: 3420161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of famotidine on oxidative drug metabolism.
    Somerville KW; Kitchingman GA; Langman MJ
    Eur J Clin Pharmacol; 1986; 30(3):279-81. PubMed ID: 2874031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of chronic heat exposure on drug metabolism in the rat.
    Ben Zvi Z; Kaplanski J
    J Pharm Pharmacol; 1980 May; 32(5):368-9. PubMed ID: 6104708
    [No Abstract]   [Full Text] [Related]  

  • 6. Interindividual differences in rates of drug oxidation in man.
    Davies DS; Thorgeirsson SS; Breckenridge A; Orme M
    Drug Metab Dispos; 1973; 1(1):411-7. PubMed ID: 4149412
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of drug metabolism by hydroxylated metabolites: cross-inhibition and specificity.
    Soda DM; Levy G
    J Pharm Sci; 1975 Dec; 64(12):1928-31. PubMed ID: 1206483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impairment of drug elimination in patients with liver disease.
    Narang AP; Datta DV; Mathur VS
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):28-32. PubMed ID: 3988389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impairment of hepatic drug metabolism in patients with acute viral hepatitis.
    Narang AP; Datta DV; Nath N; Mathur VS
    Eur J Drug Metab Pharmacokinet; 1982; 7(4):255-8. PubMed ID: 7166177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of diabetes mellitus on drug metabolism in man.
    Daintith H; Stevenson IH; O'Malley K
    Int J Clin Pharmacol Biopharm; 1976 Jan; 13(1):55-8. PubMed ID: 1248919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of drugs and carcinogens in man: antipyrine elimination as an indicator.
    Kalamegham R; Krishnaswamy K; Krishnamurthy S; Bhargava RN
    Clin Pharmacol Ther; 1979 Jan; 25(1):67-73. PubMed ID: 31258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new polymorphism of hepatic drug oxidation in man: family studies on rates of formation of antipyrine metabolites.
    Vessell ES; Penno MB
    Biochem Soc Trans; 1984 Feb; 12(1):74-8. PubMed ID: 6705993
    [No Abstract]   [Full Text] [Related]  

  • 13. [In vivo activity of drug-metabolizing enzymes in various pathological conditions].
    Krakovskiĭ ME; Ashirmetov AKh
    Vopr Med Khim; 1985; 31(1):76-9. PubMed ID: 3984279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of drug oxidation rates in man: lack of correlation with serum gamma-glutamyl transpeptidase and urinary excretion of D-glucaric acid and 6 beta-hydroxycortisol.
    Smith SE; Rawlins MD
    Eur J Clin Pharmacol; 1974; 7(1):71-5. PubMed ID: 4153008
    [No Abstract]   [Full Text] [Related]  

  • 15. A non-invasive method for the study of hepatic drug metabolism in rodents: antineoplastic drug effects on antipyrine metabolism in mice.
    Wilson VL; Larson RE; Moldowan MJ
    Chem Biol Interact; 1982 Jun; 40(2):159-68. PubMed ID: 7083391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antipyrine test in clinical pharmacology: conceptions and misconceptions.
    Vesell ES
    Clin Pharmacol Ther; 1979 Sep; 26(3):275-86. PubMed ID: 111889
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug metabolism in epileptics: in vivo and in vitro correlations.
    Sotaniemi EA; Pelkonen RO; Ahokas J; Pirttiaho HI; Ahlqvist J
    Br J Clin Pharmacol; 1978 Jan; 5(1):71-6. PubMed ID: 619937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of oxidative drug metabolism by parenteral refeeding of nutritionally depleted patients.
    Pantuck EJ; Pantuck CB; Weissman C; Gil KM; Askanazi J
    Gastroenterology; 1985 Aug; 89(2):241-5. PubMed ID: 3924720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver drug metabolism in patients undergoing open-heart surgery.
    Kairaluoma MI; Sotaniemi EA; Mokka RE; Nuutinen L; Kärkölä P; Larmi TK
    Scand J Thorac Cardiovasc Surg; 1979; 13(3):281-5. PubMed ID: 542833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of combined pre-treatment on the metabolism of antipyrine in the rat.
    Szabó I; Renczes G; Gachályi B
    Acta Physiol Hung; 1995; 83(1):51-3. PubMed ID: 7660837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.